A Study in Advanced Cancer

Clinical trial NCT01226485 · COMPLETED

Trial details

NCT number: NCT01226485
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2010-09-01
Primary completion: 2015-01-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.